HSP90AA1 and ablepharon macrostomia syndrome: DEPs including SAP, LTF, HSP90-α, AAT were enriched in these above-mentioned pathways, and were further screened out as candidate biomarkers for distinguishing AMS-susceptible individuals from AMS-resistant individuals.